Chair, John B. Buse, MD, PhD, discusses type 2 diabetes in this CME/NCPD/AAPA/IPCE activity titled “Scoring Comprehensive T2DM Management Goals: Examining the Multifaceted Effects of GLP-1 Receptor Agonists.” For the full presentation, downloadable Practice Aids, and complete CME/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at https://bit.ly/3MIcrjd. CME/NCPD/AAPA/IPCE credit will be available until June 26, 2024.